semaglutide type 2 diabetes for Prediabetes: A Guide to Preventing Obesity Drug More Than Halves

Enlist the help of a registered dietitian and nutritionist and receive personalized guidance around GLP-1 use and related concerns.

GLP-2, marketed under the brand name Mounjaro, represents a groundbreaking advancement in the management of Type 2 diabetes and obesity

Mounjaro (tirzepatide) commonly causes digestive side effects such as nausea, diarrhea, and constipation

By slowing digestion and stabilizing blood sugar, it makes it easier to eat less and stay satisfied longer.START NOWTirzepatide slows down digestionHelps you feel fuller for longer by slowing the rate at which your stomach emptiesSUPPORTS METABOLIC